RNA Dicing: A New Frontier in Cancer Therapy
Hebrew University researchers uncover RNA dicing as a key mechanism driving JAK1 oncogenic activity in endometrial cancer, paving the way for novel targeted therapies.
Hebrew University researchers uncover RNA dicing as a key mechanism driving JAK1 oncogenic activity in endometrial cancer, paving the way for novel targeted therapies.